Biopharmaceutical Company.
H.R. 6: 21st Century Cures Act.

H.R. 4292: Synchronization & Nonadherence Correction (SYNC) Act of 2015.

Education about the value of innovative new medicines. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and proposed changes to cost sharing for low income seniors.

March 2016 CMS proposed rule implementing a new Part B drug payment model.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX